Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning

doi 10.26434/chemrxiv.12003930.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)